-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The contract renewal of the national procurement and the expiration of the alliance centralized procurement one after another.
Guangzhou announced that 190 product specifications will be suspended from trading; Gansu announced that 60 product specifications will be suspended from trading
.
On March 10, the Guangzhou Public Resources Trading Center issued the "Notice on the State Organization of Centralized Procurement of Drugs and the Suspension of the Use of Expired Drugs on the Internet"
.
According to the relevant documents, the first-year procurement cycle of the third batch of nationally selected varieties will end on November 29, 2021; The 45 drugs that have expired in the national centralized procurement and the 2021 pilot expansion shall be implemented in accordance with the relevant regulations of Guangdong Province on procurement with quantity
.
According to the relevant work arrangements, the third batch of selected varieties and non-selected drugs that have expired in the national procurement module, and the 2021 pilot expansion of the expiring selected varieties and non-selected drugs in the new transaction procurement module.
From 17:00 on March 15, 2022, it will be suspended on the procurement platform of Guangzhou Pharmaceutical Group, involving 190 product regulations
.
Among them, 101 products were not selected in the third batch of national procurement, and 35 were selected
.
If there is any objection, please initiate an application (complaint) in the category of "Purchasing Transaction" through the "Drug Application and Complaint" module
.
Guangzhou announced that 190 product specifications will be suspended from trading; Gansu announced that 60 product specifications will be suspended from trading
.
On March 10, the Guangzhou Public Resources Trading Center issued the "Notice on the State Organization of Centralized Procurement of Drugs and the Suspension of the Use of Expired Drugs on the Internet"
.
According to the relevant documents, the first-year procurement cycle of the third batch of nationally selected varieties will end on November 29, 2021; The 45 drugs that have expired in the national centralized procurement and the 2021 pilot expansion shall be implemented in accordance with the relevant regulations of Guangdong Province on procurement with quantity
.
According to the relevant work arrangements, the third batch of selected varieties and non-selected drugs that have expired in the national procurement module, and the 2021 pilot expansion of the expiring selected varieties and non-selected drugs in the new transaction procurement module.
From 17:00 on March 15, 2022, it will be suspended on the procurement platform of Guangzhou Pharmaceutical Group, involving 190 product regulations
.
Among them, 101 products were not selected in the third batch of national procurement, and 35 were selected
.
If there is any objection, please initiate an application (complaint) in the category of "Purchasing Transaction" through the "Drug Application and Complaint" module
.
